Candida (CD-1)

This Cup winning high CBD strain has impressed with its vigour and stability in production. In testing THC levels have never yet exceeded 1% and CBD levels have tested between 11% and 20% making it one of the first CBD dominant cannabis strains in history. It was recognised at the Spannabis Champions Cup 2017 taking 2nd place in the CBD category.

With a ratio of 20:1, the high CBD levels and their associated anti-psychotic capabilities outweigh the relatively small amounts of THC removing the “high” and providing the patient with a non-psychoactive cannabis Sativa L plant.

CD-1 is a high yielding feminised strain with a unique lemon flavor and aroma that compliment its medicinal properties.

Candida will noticeably produce two different phenotypes; a sativa and an indica. Initial research has suggested that the sativa phenotype will produce lower, whispier yields often associated with sativa strains. We have noticed to date that the sativa pheno produces higher CBD counts. In comparison, the indica pheno will produce bigger, denser yields with lower CBD levels but still with significant CBD content. The sativa can be harder to manage and will have larger distances between the internodes making the plants more vulnerable.